Book your Virtual Summit pass at £345

Innovative solutions to the greatest challenges in pharmaceutical development

15th – 17th March 2021

The 2021 Virtual Summit covers both small molecules and biologicsnew technologies, concepts and case studies in areas such as:

  • Formulation design for poorly soluble compounds
  • The potential of nanotechnology for better deliverability
  • The latest controlled released technologies
  • Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars

2021 Speakers

Andrea Benassi


CMC – Chemistry Manufacturing & Controls, Drug Product manufacturing & Innovation, New Technology & Innovation Scientist

Dr. Fatima Bennai-Sanfourche


Director Medical device Safety, Medical Device Safety Officer

Elijahu Berkovich

Clexio Biosciences

Head of Emerging Science and Innovation

Beate Bittner


Product Optimization Franchise Leader

Jace Blackburn


Smart Device Engineer

Jeffrey T. Blue


Executive Director, Vaccine Drug Product Development PR&D

Erwan Bourles


Senior Manager, Head of Drying and Related Modelling Technologies Drug Product development Unit

Dr. Stefan Bracht


Vice President Head of Disruptive Technologies

Professor Dr. Klaus Brandenburg

Borstel Research Center

Longtime scientist at Forschungszentrum Borstel

Olivier Brass


Senior scientist, lead of research unit, research department

Sebastian Braun

LTS LOHMANN Therapie-Systeme AG

Director - Head of Formulation Development and Head of Manufacturing for Innovative Injection Systems

David Brayden

University College Dublin

Full Professor (Advanced Drug Delivery)

Scott Brown


Executive Director Device Development

Camilla Foged

University of Copenhagen

Professor Vaccine Design and Delivery Group

Twinkle Christian


Process Development Scientist, Drug Product Technologies Group

David Cipolla

Insmed Inc.

Vice President of Research

Matthew Clemente

Novo Nordisk

Corporate Vice President Delivery Systems Engineering

Bernardo Cordovez

Halo Labs

Chief Science Officer and Founder

Frederic Dargelas


Director, Head of Business Development and Alliance Management

Ranjit Dhenge


Investigator R&D

Ryan F. Donnelly

Queen's University Belfast

Chair in Pharmaceutical Technology

Sachin Dubey

Ichnos Sciences SA

Senior Associate Director, Drug product and Analytical Development

Alina Dumitru

Imperial College London

PhD Researcher

Gabriele Sadowski

TU Dortmund

Professor for Thermodynamics

Sudhakar Garad

Novartis Institutes for BioMedical Research

Global Head of Chemical and Pharmaceutical Profiling

Patrick Garidel

Boehringer Ingelheim

Head of Process, Purification and Pharma Development

Rob Gelissen

W. L. Gore & Associates – PharmBIO Division

Business Development for Drug Delivery and Packaging

David Grant

Enesi Pharma

Head of Device Development

Mark Guarraia

Novo Nordisk

Vice President, Design and User Experience

Heinrich Haas


Vice President, Formulation

Robert Hennig


Associate Director Drug Delivery & Innovation, Healthcare R&D

João Henriques


Group Leader, R&D Drug Product Development

Korinde van den Heuvel

DFE pharma

Senior Product Developer

David Hipkiss

Enesi Pharma

Chief Executive Officer

Martin Hofsäss


PostDoc Development Pharma Solutions

Shiqi Hong


Senior biopharma scientist

Kristiina M. Huttunen

University of Eastern Finland

Adjunct Professor (Docent) and Finnish Academy Research Fellow

Lynne A. Isopi


Principal Scientist, Vaccine Drug Product Development

Lynne Isopi



Arul Joseph

Avanir Pharmaceuticals

Senior Director, Pharmaceutical Development and Clinical Supply Chain

Nitin Joshi

Brigham and Women’s Hospital, Harvard Medical School

Instructor of Anesthesia, Center for Nanomedicine

Dr. Nazila Kamaly

Imperial College London

Lecturer, Chemistry

Karsten Fluegel


Postdoctoral Researcher | Drug Delivery & Innovation

Naila El Kechai


Formulation and Drug Product Team Leader

Satu Lakio


Pharmaceutical Development Director

Dr Garry Laverty

Queen’s University Belfast

Senior Lecturer in Pharmaceutical Sciences

Claus-Michael Lehr

Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)

Head, Dept. of Drug Delivery (DDEL)

Philippe Lienard


Pre-Development Science Leader

Tony Listro

Foster Delivery Science

Vice President, Technology

Rosario LoBrutto


Head of Scientific Affairs

Christian Lotz

Pfanstiehl GmbH

General Manager EMEA

Dr. Christian Lotz

Pfanstiehl GmbH

General Manager EMEA

Dr Fiona MacDougall


Director of Biopharmaceutics

Kenneth J. Mandell


Founder and CEO

Moein Moghimi

Newcastle University

Professor of Nanomedicine

Fadee Mondalek


Head of internal development

Anette Müllertz

University of Copenhagen

Professor, Head of Center

Vishal Nashine


Associate Director

Celine Ollier


PK-Biopharm Marketed Compounds

Luis Padrela

University of Limerick

Lecturer SSPC, Bernal Institute

Mafalda Paiva


Group Leader, R&D Analytical Development

Rick Panicucci

QED Therapeutics

Senior Vice President CMC

Luigi Boltri, Ph.D.

Adare Pharma Solutions

Senior. Director Pharmaceutical Sciences, Business Support and New Technologies,

Carolin Riehl


Principal Scientist | Lab Head Drug Delivery & Innovation

Christophe Roberge


Senior Technology Advisor

Dr Ana L Gomes dos Santos


Principal Scientist

Luis Santos


Drug Delivery Leader, Biopharmaceutical Development, Cell and Gene Therapies, Innovation

Stefan Schneid


Laboratory Head Formulation Development Parenterals

John C. Shelly



Sarah Stevens

Quotient Sciences

Vice President, Drug Development Sciences

Aaron Stewart


Associate Principal Scientist

Dr. Timo Taghizadeh

tesa Labtec GmbH

Head of Business Development & Marketing

Stephen Tindal


Director of Science & Technology

Vivek Trivedi

University of Kent

Lecturer in Drug Delivery, Medway School of Pharmacy

Ijeoma F. Uchegbu

University College London

Chair in Pharmaceutical Nanoscience

Alex Vasiev

Oval Medical Technologies

Manager of Device Development

Bharathi Vellalore


Scientist, Drug Product Development Discovery, Product Development and Supply

Murty Vyakarnam

Oculinea Inc

Co-founder & Chief Executive Officer

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

Shogo Warashina

SE Tylose GmbH & Co.KG

Technical Sales Manager

Daryl Williams

Imperial College

Professor of Particle Science

Latest News

Nanoform’s Clinical Study Indicates Positive Interim Results

Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful.

Silicones for drug infusion devices - From hospital to wearable: how silicones are used at different scales to help patients live a normal life

This e-book presents an overview of the medical, industrial, compliance and economic advantages and challenges in the use of silicone materials in Infusion as a method of drug delivery. The unique properties of silicones along with their longstanding, proven track record in medical applications, can enable innovative solutions that improve the quality and efficacy of infusion care.

PMC Isochem To accelerate Polyamino acids Business as part of ISODEL® Drug Delivery offer, a unique One Stop Shop for NCA and PAA

PMC Isochem announces today that it is accelerating the strategic development and manufacture of polyamino acids (PAA) as functional excipients used in complex formulations and drug delivery solutions. Based on its own internal resources and endowed with a fully integrated know-how as well as its leading position in the manufacture of critical Activated Amino Acids (NCA), PMC Isochem becomes the reliable supplier of PAA and the sustainable partner.